Cannapharmarx Inc (CPMD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2019 | 12-2018 | 12-2017 | 12-2016 | 12-2015 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -20,451 | -3,094 | -7 | -1,001 | -11,743 |
| Depreciation Amortization | 4,564 | 2,072 | N/A | N/A | 12 |
| Accounts receivable | -500 | N/A | N/A | N/A | 1 |
| Accounts payable and accrued liabilities | 226 | N/A | 5 | 8 | 320 |
| Other Working Capital | -1,515 | 54 | 7 | 251 | 379 |
| Other Operating Activity | 13,882 | 28 | -5 | 720 | 8,483 |
| Operating Cash Flow | $-3,795 | $-941 | $0 | $-22 | $-2,549 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -5 | N/A | N/A | N/A | 86 |
| Net Acquisitions | N/A | -727 | N/A | N/A | N/A |
| Other Investing Activity | -42 | 0 | 0 | 0 | 50 |
| Investing Cash Flow | $-47 | $-727 | $0 | $0 | $136 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 1,550 | 2,072 | 0 | N/A | N/A |
| Debt Issued | 1,340 | N/A | N/A | 20 | 0 |
| Common Stock Issued | N/A | N/A | N/A | N/A | 805 |
| Common Stock Repurchased | -99 | N/A | N/A | N/A | N/A |
| Other Financing Activity | 475 | 60 | 0 | 0 | 6 |
| Financing Cash Flow | $3,266 | $2,132 | $0 | $20 | $811 |
| Exchange Rate Effect | 113 | N/A | N/A | N/A | N/A |
| Beginning Cash Position | 464 | 0 | 0 | 3 | 1,605 |
| End Cash Position | 2 | 464 | 0 | 0 | 3 |
| Net Cash Flow | $-463 | $464 | $0 | $-3 | $-1,603 |
| Free Cash Flow | |||||
| Operating Cash Flow | -3,795 | -941 | 0 | -22 | -2,549 |
| Capital Expenditure | -5 | N/A | N/A | N/A | -2 |
| Free Cash Flow | -3,800 | -941 | 0 | -22 | -2,551 |